# A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115)

> **NCT00837941** · PHASE2 · WITHDRAWN · sponsor: **Merck Sharp & Dohme LLC**

## Conditions studied

- Painful Diabetic Neuropathy

## Interventions

- **DRUG:** Comparator: A: Pregabalin
- **DRUG:** Comparator: B: Duloxetine
- **DRUG:** Comparator: C: Diphenhydramine hydrochloride

## Key facts

- **NCT ID:** NCT00837941
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-04
- **Primary completion:** 2009-08
- **Final completion:** 2009-09
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00837941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00837941, "A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00837941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*